|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
6/29/2011 7:12:25 AM
SciFluor Life Sciences, LLC, a drug development technology company that provides a revolutionary capability to enable late-stage fluorination of pharmaceutical drug candidates, announced that it has appointed Arthur Hiller, recent CEO of venture-backed cardiovascular device start-up Heartscape Technologies, Inc., and former Senior Vice President at Millennium Pharmaceuticals, as its Chief Executive Officer. The company utilizes patented technology developed by Tobias Ritter, PhD., Associate Professor of Chemistry and Chemical Biology at Harvard University, to provide drug companies with a new tool in their arsenal to increase the likelihood of bringing new drug candidates to market.
|
|
|
|
|
|
|
|
|
|
|